[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Q Fever Drug pipeline Report 2020- Current Status, Phase, Mechanism, Route of Administration, Companies, and Clinical Trials of Pre-clinical and Clinical Drugs

October 2019 | 20 pages | ID: Q33ADBC0E019EN
VPAResearch

US$ 1,699.00

E-mail Delivery (PDF)

Download PDF Leaflet

Wire Transfer
Checkout Later
Need Help? Ask a Question
Q Fever Drug pipeline report- 2020 is an annual R&D review of Q Fever pipeline candidates. The report presents the current status of all major Q Fever therapeutic compounds. Detailed insights into Q Fever pipeline development, current status, companies, drug profiles and Q Fever preclinical and clinical trials are included.

2020 Q Fever Pipeline Market Insights
Q Fever disease overview, 2020 pipeline review, insights into leading companies, dominant mechanism of action, majority of administration route of Q Fever therapies, pipeline by phase and others are included.

Q Fever pipeline Drug profiles-
Active and inactive drug profiles covering information including drug name/synonym, sponsor/collaborators/Developer/originator, drug mechanism, route of administration, orphan drug status, NME, phase, development status, and others are included.

Q Fever Therapeutic Drug candidates
Both active and inactive Q Fever pipeline drug candidates are included in the report

Q Fever Clinical Trials and preclinical Studies
Q Fever In-vitro and In-vivo studies, discovery stage and pre-clinical stage trial details, Clinical trial titles, duration, location, phase, sponsors, and other details are provided.

Q Fever pipeline market developments
Q Fever Pipeline market news and deals including mergers, acquisitions, approvals, collaborations, trial initiations, results, investments, licensing opportunities and others are provided.

Q Fever pipeline companies in active development
The report analyzes Q Fever pipeline of the below companies-

Aradigm Corp, EpiVax

Report Coverage

What to look out for in 2020
Drugs moving from early stage to mid-to-late stages and drugs to look after in 2020 are included

Pipeline Snapshot
Pipeline candidate count - Drug by phase, mechanism of action, route of administration, designation and others

Companies
2 Companies investing in Q Fever pipeline from discovery stage to pre-registration phase are included

Drug profiles
Over 10 details of each Q Fever pipeline candidate are included

Company Profiles
Business overview and contact details of all companies operating in the industry are provided

Market Developments
News, Developments and other recent industry developments are included
1. Q FEVER PIPELINE MARKET INSIGHTS, 2020

1.1 Q Fever Disease Overview
1.2 Q Fever Drug Pipeline Snapshot, 2020
  1.2.1 Q Fever Pipeline Drugs by Phase
  1.2.2 Q Fever Pipeline Drugs by Company
  1.2.3 Q Fever Pipeline Drugs by Mechanism of Action
  1.2.4 Q Fever Pipeline Drugs by Route of Administration

2. Q FEVER COMPANY WISE PIPELINE DETAILS

Aradigm Corp Q Fever Pipeline Drugs
  Company Profile
  Drug Candidate Details
EpiVax Q Fever Pipeline Drugs
  Company Profile
  Drug Candidate Details

3. Q FEVER DRUG PIPELINE PROFILES

3.1 Discovery and Preclinical Drug Profiles
3.2 Phase 1 Drug Profiles
3.3 Phase 2 Drug Profiles
3.4 Phase 3 Drug Profiles

4. Q FEVER PIPELINE NEWS AND DEVELOPMENTS

5. APPENDIX

5.1 Primary and Secondary Research Methodology
5.2 Publisher Expertize
5.3 Contacts


More Publications